Bimatoprost ophthalmic solution 0.01% is a prostaglandin analog indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
A trio of ASCRS presentations collectively offer insight to surgeons, suggesting that glaucoma drops harm meibomian glands, ...
India, April 13 -- Life Biosciences, a clinical-stage biotechnology company focused on reversing diseases of aging, has received clearance from the U.S. Food and Drug Administration (FDA)-the ...
A new study suggests that something as simple as how you position your head during sleep could influence eye health in ...
Policymakers and eye-care providers keen to turn India's glaucoma challenge into a global model of sustainable eye care: Our Bureau, Bengaluru Friday, April 10, 2026, 16:15 Hrs [I ...
It’s been a little over two months since President Donald Trump’s direct-to-consumer pharmaceutical site, TrumpRx, launched, ...
Bimatoprost ophthalmic solution 0.01% is a prostaglandin analog indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
India Today on MSN
Think your pillow is harmless? This study says otherwise
A new study links pillow height to changes in eye pressure during sleep. Experts say your sleeping posture may matter more ...
New SOL-1 post-hoc analyses presented at VBS reinforce AXPAXLI’s unmatched durability in wet AMD with sustained disease controlAXPAXLI ...
The Beijing biotech has been set up to tap into the growing interest in macrocyclic peptides as an emerging treatment ...
New SOL-1 post-hoc analyses presented at VBS reinforce AXPAXLI's unmatched durability in wet AMD with sustained disease control AXPAXLI demonstrated robust CSFT control with a median time of 39 weeks ...
A smart contact lens described in a research paper on Wednesday combines therapeutic and diagnostic capabilities for glaucoma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results